The General Hospital Corporation, doing business as Massachusetts General Hospital (MGH), received a $118,089 Project Grant award from the Agency for Healthcare Research and Quality (AHRQ) under the Research on Healthcare Costs, Quality and Outcomes (CFDA 93.226) federal grant program. The two-year award, with a start date of August 1, 2024, will fund the development and testing of a clinical decision support (CDS) tool to improve iron deficiency anemia screening and management for pregnant individuals at high risk of postpartum hemorrhage. In Phase I, the project will use machine learning to create a predictive model for identifying high-risk patients based on data available by the end of the second trimester. Phase II will then evaluate the efficacy of the CDS tool in reducing anemia prevalence prior to delivery through a randomized controlled trial. This research aims to accelerate the application of artificial intelligence-aided tools in obstetric care and enhance maternal health outcomes.
Generated 2/25/25, 5:23 AM